Additionally, this study also revealed higher serum NT-proBNP and HMGB1 levels and lower serum SIRT1 levels in the poor prognosis group than in the excellent prognosis group, due to the increase of NT-proBNP, a sensitive indicator of cardiac function, being usually associated with increased cardiac burden and cardiac insufficiency. Here, HMGB1 is linked to heart failure.